Evidence map›Paper›PMID 38443675›Full record

ArticleScientific reports2024

Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.

Sujuan Zhang, Zui Chen, Jie Ling, Yuhua Feng, Yangchun Xie, Xianling Liu, Chunhong Hu, Tao Hou

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sujuan ZhangDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Zui ChenDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Jie LingDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Yuhua FengDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Yangchun XieDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Xianling LiuDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Chunhong HuDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Tao HouDepartment of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. houtao@csu.edu.cn.ORCID http://orcid.org/0000-0001-8158-8114

Funding

National Natural Science Foundation of China 81802476Natural Science Foundation of Hunan Province 2021JJ40882Natural Science Foundation of Hunan Province 2022JJ40682Science and Technology Program of Hunan Province 2021SK53515
6 · The paper itself

Abstract

Much evidence has accumulated to show that inflammation and nutritional status are associated with the prognosis of patients with various cancers. The present study was designed to explore the prognostic role of the LANR in NPC patients receiving definitive radiotherapy and to construct a nomogram for predicting patient survival. This study retrospectively reviewed 805 NPC patients (604 in the training cohort and 201 in the validation cohort) who received definitive radiotherapy between January 2013 and December 2019. The clinical data and pretreatment laboratory test data, including lymphocyte count, neutrophil count, and serum ALB concentration, were collected for all patients. The LANR was calculated as the albumin × lymphocyte/neutrophil ratio. Patients in the training cohort and validation cohort were categorized into high-LANR and low-LANR groups according to the corresponding cutoff values. The independent prognostic factors for overall survival (OS), progression-free survival (PFS), relapse-free survival (RFS), and metastasis-free survival (MFS) were evaluated by univariate and multivariate Cox regression analyses, and a nomogram was subsequently constructed. The performance of the nomogram was evaluated by the concordance index (C-index) and calibration curve. A low LANR (< 14.3) was independently associated with worse OS, PFS and MFS in NPC patients. A prognostic prediction nomogram was established based on T stage, N stage, Eastern Cooperative Oncology Group (ECOG) score, treatment modality, and LANR and was validated. The C-indices of the nomograms for OS and PFS in the training cohort were 0.729 and 0.72, respectively. The C-indices of the nomograms for OS and PFS in the validation cohort were 0.694 and 0.695, respectively. The calibration curve revealed good consistency between the actual survival and the nomogram prediction. Patients with NPC with low pretreatment LANR had a poor prognosis. The nomogram established on the basis of the LANR was efficient and clinically useful for predicting survival in NPC patients who underwent definitive radiotherapy.

Indexed as

Nasopharyngeal NeoplasmsNomogramsAlbuminsHumansLymphocytesNasopharyngeal CarcinomaNeutrophilsPrognosisRetrospective StudiesAlbuminsAlbuminLymphocyteNasopharyngeal carcinomaNeutrophilPrognosis

Identifiers

PMID38443675
PMCPMC10915143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.